Prof. Feza DEYMEER | AVESİS

Research Information System

Publications & Works

Publication Network

Articles 30

1. Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy

Tezen D., Khojakulov Z., GÜNDÜZ A., Deymeer F., Demirbilek V., Başak A. N.

Neurological Sciences , vol.45, no.12, pp.5967-5971, 2024 (SCI-Expanded)

2. Investigation of a Novel Recessive Mutation in Acetylcholine Receptor Epsilon-Subunit with Slow-Channel Kinetics Causing Congenital Myasthenia Reveals Subunit-Specific Contribution of Cys-Loop Length to Receptor Activation

Shen X., Shen S., Zhao Y., Di L., Durmus H., Deymeer F., et al.

ANNALS OF NEUROLOGY , vol.92, 2022 (SCI-Expanded)

3. Lumbar Spinal Stenosis: A Rare Presentation of Hereditary Transthyretin Amyloidosis

Cakar A., Atmaca M. M., Kotan D., Durmus H., Deymeer F., Oflazer P., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.59, no.1, pp.77-79, 2022 (SCI-Expanded)

4. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine

Durmus H., Sticht H., Ceylaner S., Hashemolhosseini S., Deymeer F.

ACTA NEUROLOGICA BELGICA , vol.121, no.6, pp.1755-1760, 2021 (SCI-Expanded)

5. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , vol.36, pp.1676-1688, 2021 (SCI-Expanded)

6. History of Myasthenia Gravis Revisited

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.2, pp.154-162, 2021 (SCI-Expanded) Sustainable Development

Sustainable Development

7. Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database

Tunca C., Seker T., Akcimen F., Coskun C., Bayraktar E., Palvadeau R., et al.

HUMAN MUTATION , vol.41, no.8, 2020 (SCI-Expanded)

8. Nusinersen in SMA 2 and 3 Risks vs benefits

NEUROLOGY , vol.95, no.4, pp.151-152, 2020 (SCI-Expanded)

9. EVALUATION OF REPETITIVE NERVE STIMULATION WITH DIFFERENT STIMULATION FREQUENCIES IN PATIENTS WITH MYASTHENIA GRAVIS

Sirin N. G., KOCASOY ORHAN E., Oguz Akarsu E., DURMUŞ TEKÇE H., Deymeer F., BASLO M. B.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.83, no.3, pp.197-203, 2020 (ESCI)

10. Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome

Yildiz Celik S., DURMUŞ TEKÇE H., YILMAZ V., SARUHAN DİRESKENELİ G., Gulsen Parman Y., Serdaroglu Oflazer P., et al.

ACTA NEUROLOGICA BELGICA , vol.120, no.1, pp.133-140, 2020 (SCI-Expanded)

11. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

ÇEBI M., DURMUŞ H., YILMAZ V., YENTÜR S. P., AYSAL F., OFLAZER P., et al.

Clinical and experimental immunology , vol.197, pp.214-221, 2019 (SCI-Expanded)

12. Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments

Cakar A., Tekce H. D., Deymeer F., Serdaroglu P. O., Parman Y. G.

TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, pp.105-111, 2017 (ESCI)

13. Prompt Response to Prednisone Predicts Benign Course in MuSK-MG

Gungor-Tuncer O., Yilmaz V., Toker A., Saruhan-Direskeneli G., Gulsen-Parman Y., Oflazer-Serdaroglu P., et al.

EUROPEAN NEUROLOGY , vol.78, pp.137-142, 2017 (SCI-Expanded)

14. Differential Diagnosis Approach to Bilateral Peripheral Facial Paralysis: A Case Report

Akcakaya N. H., Gokmen M. H. A., Parman Y. G., Deymeer F., Oflazer P.

TURKISH JOURNAL OF NEUROLOGY , vol.22, no.4, pp.196-198, 2016 (ESCI)

15. Myasthenia gravis after botulinum toxin type A injection Botulinum toksin tip A enjeksiyonu sonrası açığa çıkan myasthenia gravis olgusu

Tekce H., Deymeer F., Serdaroglu P. O., Parman Y.

Turk Noroloji Dergisi , vol.22, no.3, pp.143-144, 2016 (Scopus)

16. Facial and Skeletal Muscle Magnetic Resonance Imaging in Oculopharyngodistal Myopathy

DURMUŞ TEKÇE H., Dursun M., Sencer S., Deymeer F., Oflazer-Serdaroglu P.

TURKISH JOURNAL OF NEUROLOGY , vol.20, no.4, pp.121-125, 2014 (ESCI)

17. GFPT1-myasthenia Clinical, structural, and electrophysiologic heterogeneity

Selcen D., Shen X., Milone M., Brengman J., Ohno K., Deymeer F., et al.

NEUROLOGY , vol.81, no.4, pp.370-378, 2013 (SCI-Expanded)

18. Painful Polyneuropathy in Poems Syndrome with Multicentric Castleman Disease: A Case Report

Gur S., Deymeer F., Oflazer P., Parman Y. G.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.48, no.3, pp.211-214, 2011 (SCI-Expanded)

19. NATURAL HISTORY OF SMA IIIb: MUSCLE STRENGTH DECREASES IN A PREDICTABLE SEQUENCE AND MAGNITUDE Reply

Deymeer F., Serdaroglu P., Parman Y., PODA M.

NEUROLOGY , vol.72, no.23, pp.2058, 2009 (SCI-Expanded)

20. B cell regulating activity in patients with myasthenia gravis

Yilmaz V., Oflazer P., Parman Y., Deymeer F., Saruhan-Direskeneli G.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.179, 2008 (SCI-Expanded)

21. X-linked Charcot-Marie-Tooth disease and multiple sclerosis [4]

PARMAN Y., CIFTCI F., POYRAZ M., HALEFOGLU A. M., Oge A. E., ERAKSOY M., et al.

Journal of Neurology , vol.254, no.7, pp.953-955, 2007 (SCI-Expanded)

22. Polymorphisms of interferon-γ, interleukin-10, and interleukin-12 genes in myasthenia gravis

Yilmaz V., Tutuncu Y., HASBAL N. B., Parman Y., SERDAROGLU P., Deymeer F., et al.

Human Immunology , vol.68, no.6, pp.544-549, 2007 (SCI-Expanded)

23. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis

Deymeer F., GUNGOR-TUNCER O., Yilmaz V., Parman Y., SERDAROGLU P., OZDEMIR C., et al.

Neurology , vol.68, no.8, pp.609-611, 2007 (SCI-Expanded)

24. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis

Baslo M. B., Deymeer F., SERDAROGLU P., Parman Y., OZDEMIR C., CUTTINI M.

NEUROMUSCULAR DISORDERS , vol.16, no.7, pp.454-458, 2006 (SCI-Expanded)

25. Slow-channel mutation in acetylcholine receptor alpha M4 domain and its efficient knockdown

Shen X., Deymeer F., Sine S. M., Engel A. G.

ANNALS OF NEUROLOGY , vol.60, no.1, pp.128-136, 2006 (SCI-Expanded)

26. HLA-DQ polymorphism in Turkish patients with myasthenia gravis

Saruhan-Direskeneli G., Kilic A., Parman Y., Serdaroglu P., Deymeer F.

HUMAN IMMUNOLOGY , vol.67, pp.352-358, 2006 (SCI-Expanded) Sustainable Development

Sustainable Development

27. Fasciculations, autonomic symptoms and limbic encephalitis: A thymoma-associated Morvan's-like syndrome

Deymeer F., AKCA S., KOCAMAN G., Parman Y., Serdaroglu P., OKTEM-TANOR O., et al.

EUROPEAN NEUROLOGY , vol.54, no.4, pp.235-237, 2005 (SCI-Expanded)

28. Molecular and clinical study of two myotonic dystrophy homozygotes.

AKBAS F., SERDAROGLU P., DEYMEER F., AYSAL F., Erginel-Unaltuna N.

Journal of medical genetics , vol.38, no.11, 2001 (SCI-Expanded)

29. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve.

DEYMEER F., Oge A. E., SERDAROĞLU P., YAZICI J., OZDEMIR C., BASLO A.

Muscle & nerve , vol.21, pp.643-6, 1998 (SCI-Expanded)

30. EMERY-DREIFUSS MUSCULAR-DYSTROPHY WITH UNUSUAL FEATURES

DEYMEER F., OGE A. E., BAYINDIR C., KAYMAZ C., NISANCI Y., ADALET K., et al.

MUSCLE & NERVE , vol.16, no.12, pp.1359-1365, 1993 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 35

1. Clinical And Genetic Characteristics of Bethlem Myopathy Patients from Turkey

Yunisova G., Ceylaner S., Deymeer F., Oflazer P., Durmus H., Parman Y.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 May 2020, vol.27, pp.1158, (Summary Text)

2. GNE MYOPATHY in TURKEY: CLINICAL FEATURES AND NOVEL MUTATIONS

Durmus H., Ceylaner S., Parman F. Y., Deymeer F., Serdaroglu P.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

3. Clinical and Genetic Features in X-Linked Charcot-Marie-Tooth Neuropathy (CMT-X) Patients from Turkey

Parman Y., Durmus H., Candayan A., Akcay H. I., Yunisova G., Ulukan Ç., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

4. Congenital Myasthenic Syndromes (CMS) Due to Impaired Principal Coupling Pathway in the. Subunit of Muscle Acetylcholine Receptor (AChR)

Shen X., Brengman J., Shen S., Durmus H., Preethish-Kumar V., Yuceyar N., et al.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

5. Clinical and Genetic Heterogeneity in Charcot-Marie-Tooth Neuropathy Type 2 Patients from Turkey

Durmus H., Akcay H. I., Sivaci M., Serdaroglu P., Deymeer F., Battaloglu E., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

6. Clinical and Genetic Heterogeneity in Familial ALS Patients from Turkey

Durmus H., Sezgin M., Samanci B., Ozoguz A., Deymeer F., Serdaroglu P., et al.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, (Summary Text)

7. TÜRK TOPLUMUNDA EN SIK RASTLANILAN MİYOFOSFORİLAZ (PYGM) MUTASYONLARI: MCARDLE HASTALIĞININ GENETİK TANISI İÇİN YENİ NESİL DİZİLEME

İNAL GÜLTEKİN G., TOPTAŞ HEKİMOĞLU B., GÖRMEZ Z., DURMUŞ TEKÇE H., SAĞIROĞLU M. Ş., DEMİRCİ H., et al.

51. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 03 December 2015, (Summary Text) Sustainable Development

Sustainable Development

8. Myasthenia gravis te B ve Düzenleyici B Hücreleri

YILMAZ V., Rozen L. P., Oflazer P., Aysal F., PARMAN F. Y., DİRESKENELİ R. H., et al.

7. DETAE Günleri, İstanbul, Turkey, 12 - 13 November 2015, (Summary Text)

9. Does high pass filtering proposed for concentric needle electrode recording affect the calculated neuromuscular jitter in myasthenia gravis

Şirin G., KOCASOY ORHAN E., Durmuş H., BASLO M. B., DEYMEER F.

THE 15TH EUROPEAN CONGRESS ON CLINICAL NEUROPHYSIOLOGY, 30 September - 02 October 2015

10. Myasthenia gravis hastalarının elektrofizyolojik incelemelerine retrospektif bir bakış

ŞİRİN N. G., KOCASOY ORHAN E., DURMUŞ TEKÇE H., BASLO M. B., DEYMEER F.

31. ulusal klinik nörofizyoloji EEG-EMG kongresi, Turkey, 8 - 12 April 2015

11. Differential cytokine changes in myasthenia gravis patients with antibodies against AChR and Musk

Yilmaz V., Oflazer P., Aysal F., Durmus H., Poulos K., Parman Y., et al.

12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, 9 - 13 November 2014, vol.275, pp.212-213, (Summary Text)

12. Genotypic and phenotypic presentation of TTR-FAP in Turkey

Durmus H., Matur Z., Atmaca M. M., PODA M., Oflazer-Serdaroglu P., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

13. Exome sequencing vs phenotype directed gene screening in CMT patients from Turkey

Sivaci M., Parman Y., Gonzaga-Jauregui C., Pehlivan D., Durmus H., Deymeer F., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

14. Genotype-Phenotype Evaluation In 476 Turkish Dystrophinopathy Patients

Durmuş H., GEYİK F., ERGINEL-UENALTUNA N., PODA M., Çakar A., Altınkaya A., et al.

The 66th AAN Annual Meeting, Philadelphia, United States Of America, 26 April 2014 - 03 May 0215, pp.96, (Full Text)

15. P420 EMG In Pediatric Population Was It Worth It

KOCASOY ORHAN E., BAYSAL KIRAÇ L., YALINAY DİKMEN P., MATUR Z., BASLO M. B., ERTAŞ M., et al.

30th International Congress on Clinical Neurophysiology of the IFCN 2014, Germany, 20 - 23 March 2014, vol.125, pp.162

16. Investigation of 11 Patients with GFPT1-Myasthenia Reveals Clinical, Structural, and Electrophysiologic Heterogeneity

Selcen D., Shen X. M., Milone M., Brengman J., Ohno K., McQuillen M., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

17. Clinical and Genetic Characteristics of Five Turkish Families with UBQLN2 Mutations

Durmus H., Ozoguz A., Deymeer F., Serdaroglu P., Aysal F., Ertas M., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

18. Distribution and Severity of Weakness in Patients with Polymyositis and Dermatomyositis: Different Pathophysiology, Different Affected Muscle Groups

Durmus H., Deymeer F., Parman Y., Serdaroglu P.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

19. Cytokine levels in peripheral cell culture without B cell in myasthenia gravis patients

Yilmaz V., Oflazer P., Aysal F., Parman Y. G., Deymeer F., Saruhan-Direskeneli G.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, vol.253, pp.167, (Summary Text)

20. Skeletal muscle pathology in the experimental animal model of muscle-specific receptor tyrosine kinase (MuSK) related myasthenia gravis

Ulusoy C., Yilmaz V., Trakas N., Poulas K., Armagan H., Turan S., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, vol.253, pp.51-52, (Summary Text)

21. **Association of HLA-DRB114, DRB116 and HLA-DQ5 with MuSK-myasthenia gravis in Turkish patients**

Hajibehzad M. A., Yilmaz V., Parman Y. G., Aysal F., Oflazer P., Deymeer F., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, vol.253, pp.79-80, (Summary Text)

22. Conduction blocks in Charcot-Marie-Tooth 1A

PARMAN Y., Kocasoy-Orhan E., MATUR Z., OFLAZER-SERDAROGLU P., BATTALOGLU E., POYRAZ M., et al.

21st Meeting of the European-Neurological-Society, Lisbon, Portugal, 28 - 31 May 2011, vol.258, pp.110

23. Central nervous system involvement in Duchenne Muscular Dystrophy

Yayla V., Oge A. E., Kalem S. A., Gokyigit A., Purcu G., Gurvit H., et al.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

24. Comparison of quantitative Myasthenia Gravis score between ANTI-MuSK positive and ANTI-MuSK negative patients

Gungor-Tuncer O., Kiyan E., Yilmaz V., Parman Y., Serdaroglu P., Saruhan-Direskeneli G., et al.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

25. Lung-muscle functions and sleep related breathing disorders in patients with amyotrophic lateral sclerosis

Kiyan E., Pur L., Cuhadaroglu C., Parman Y., Deymeer F., Serdaroglu P.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

26. Comparison of thymus pathology of anti-MuSK positive with -MuSK negative and -AChR positive myasthenia gravis

Bayindir C., Gungor-Tuncer O., Parman Y., Serdaroglu P., Saruhan-Direskeneli G., Toker A., et al.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

27. Low levels of BAFF in the serum of patients

Yilmaz V., Gungor-Tuncer O., Parman Y., Serdaroglu P., Deymeer F., Sayuhan-Direskeneli G.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

28. MRI showing selective muscle involvement in SMA III

Dursun M., Bilgin E., Serdaroglu P., Parman Y., Poda M., Deymeer F., et al.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

29. Clinical aspects of peripheral nerve hyperexcitability syndromes

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16

30. Allele-specific silencing of a novel human slow-channel mutation in TMD4 of the muscle AChR alpha subunit by RNA interference

Shen X., Deymeer F., Engel A.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

31. Lung-muscle function tests and sleep related breathing disorders in patients with myopathies

Kiyan E., Pur L., Cuhadaroglu C., Parman Y., Deymeer F., Serdaroglu P.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

32. Riboflavin responsive 'glutaric aciduria' with prominent diaphragm weakness: a case report

Kiyan E., Cuhadaroglu C., Tat B., Parman Y., Deymeer F., Serdaroglu P.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

33. In vitro immune response in Myasthenia Gravis patients with ANTI-MuSK or ANTI-AChR antibodies

Yilmaz V., Gungor-Tuncer O., Parman Y., Serdaroglu P., Deymeer F., Saruhan-Direskeneli G.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

34. Longitudinal study confirming muscle strength loss in SMAIIIb

DEYMEER F., SERDAROGLU P., PARMAN Y., PODA M., Erginel-Unaltuna N.

10th International Congress of the World-Muscle-Society, Iguassu Falls, Brazil, 28 September - 10 October 2005, vol.15, pp.724, (Summary Text)

35. Duchenne Muskuler Distrofili Çocuklarda Fonksiyonel Aktivite Düzeyleri

YALIMAN A., Dilşen G., Serdaroğlu P., DEYMEER F., ORAL A., SİNDEL D., et al.

14.Ulusal Fizik Tedavi ve Rehabilitasyon Kongresi, Aydın, Turkey, 10 - 15 May 1993, pp.38, (Full Text)

Books 1

1. Juvenil Myastenia Gravis

DURMUŞ TEKÇE H., DEYMEER F.

in: ÇOCUK VE ERGENDE NÖROLOJİK HASTALIKLARAYAKLAŞIM REHBER KİTABI, Ayşın DerventSemih AytaÖzlem ÇokarDerya Uludüz, Editor, Türk Nöroloji Derneği, pp.320-324, 2015

Other Publications 1

1. EMG in pediatric population – Was it worth it?

KOCASOY ORHAN E., BAYSAL KIRAÇ L., Yalınay Dikmen P., Matur Z., BASLO M. B., ERTAŞ M., et al.

Presentation, pp.162, 2014

Metrics

Publication

67

Publication (WoS)

58

Publication (Scopus)

29

Citation (WoS)

350

H-Index (WoS)

10

Citation (Scopus)

420

H-Index (Scopus)

10

Citation (Scholar)

312

H-Index (Scholar)

6

Project

9

UN Sustainable Development Goals